Search Results for "clozapine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for clozapine. Results 1 to 3 of 3 total matches.
In Brief: REMS Removal for Clozapine
The Medical Letter on Drugs and Therapeutics • Mar 27, 2025 (Issue 5103)
In Brief: REMS Removal for Clozapine ...
The FDA has announced that prescribers, pharmacies,
and patients are no longer required to participate in
a Risk Evaluation and Mitigation Strategy (REMS)
program for the second-generation antipsychotic drug
clozapine (Clozaril, and others).
Med Lett Drugs Ther. 2025 Mar 27;67(5103):1 doi:10.58347/tml.2025.5103a | Show Introduction Hide Introduction
Lumateperone (Caplyta) for Schizophrenia
The Medical Letter on Drugs and Therapeutics • Jul 27, 2020 (Issue 1603)
in efficacy over
first-generation drugs, except for clozapine (Clozaril,
and others) for treatment-resistant ...
The FDA has approved lumateperone (Caplyta —
Intracellular Therapies), an oral second-generation
antipsychotic, for once-daily treatment of schizophrenia
in adults. It is the 13th second-generation antipsychotic
drug to be approved by the FDA for this indication.
Drugs for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Feb 22, 2021 (Issue 1618)
other antipsychotics, it may increase the risk of
mortality in elderly patients with psychosis.
Clozapine (Clozaril ...
The motor symptoms of Parkinson's disease (PD) are
caused primarily by degeneration of dopaminergic
neurons in the substantia nigra. The nonmotor symptoms
of the disease are thought to be caused by degeneration of
other neurotransmitter systems. No disease-modifying
drugs are available for treatment of PD.